The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Nat Cell Biol. 2024 Aug;26(8):1233-1246. doi: 10.1038/s41556-024-01460-5. Epub 2024 Jul 18.
OTX2 is a transcription factor and known driver in medulloblastoma (MB), where it is amplified in a subset of tumours and overexpressed in most cases of group 3 and group 4 MB. Here we demonstrate a noncanonical role for OTX2 in group 3 MB alternative splicing. OTX2 associates with the large assembly of splicing regulators complex through protein-protein interactions and regulates a stem cell splicing program. OTX2 can directly or indirectly bind RNA and this may be partially independent of its DNA regulatory functions. OTX2 controls a pro-tumorigenic splicing program that is mirrored in human cerebellar rhombic lip origins. Among the OTX2-regulated differentially spliced genes, PPHLN1 is expressed in the most primitive rhombic lip stem cells, and targeting PPHLN1 splicing reduces tumour growth and enhances survival in vivo. These findings identify OTX2-mediated alternative splicing as a major determinant of cell fate decisions that drive group 3 MB progression.
OTX2 是一种转录因子,也是髓母细胞瘤(MB)中的已知驱动因子,在肿瘤的一部分中扩增,在大多数 3 组和 4 组 MB 中过度表达。在这里,我们证明了 OTX2 在 3 组 MB 剪接中的非典型作用。OTX2 通过蛋白质-蛋白质相互作用与剪接调节剂复合物的大组装体结合,并调节干细胞剪接程序。OTX2 可以直接或间接与 RNA 结合,这可能部分独立于其 DNA 调节功能。OTX2 控制一种促进肿瘤发生的剪接程序,该程序在人类小脑菱形唇起源中得到反映。在 OTX2 调节的差异剪接基因中,PPHLN1 在最原始的菱形唇干细胞中表达,靶向 PPHLN1 剪接可减少肿瘤生长并提高体内存活率。这些发现确定了 OTX2 介导的选择性剪接作为驱动 3 组 MB 进展的细胞命运决定的主要决定因素。